Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer
Open accessThe DOI matches its Crossref record; 265 of the 271 references it cites were found in a registry or an index; 89 of the 187 sources its claims cite were checked for support.
Abstract
Brain-derived neurotrophic factor (BDNF) is one of the most distributed and extensively studied neurotrophins in the mammalian brain. BDNF signals through the tropomycin receptor kinase B (TrkB) and the low affinity p75 neurotrophin receptor (p75NTR). BDNF plays an important role in proper growth, development, and plasticity of glutamatergic and GABAergic synapses and through modulation of neuronal differentiation, it influences serotonergic and dopaminergic neurotransmission. BDNF acts as paracrine and autocrine factor, on both pre-synaptic and post-synaptic target sites. It is crucial in the transformation of synaptic activity into long-term synaptic memories. BDNF is considered an instructive mediator of functional and structural plasticity in the central nervous system (CNS), influencing dendritic spines and, at least in the hippocampus, the adult neurogenesis. Changes in the rate of adult neurogenesis and in spine density can influence several forms of learning and memory and can contribute to depression-like behaviors. The possible roles of BDNF in neuronal plasticity highlighted in this review focus on the effect of antidepressant therapies on BDNF-mediated plasticity. Moreover, we will review data that illustrate the role of BDNF as a potent protective factor that is able to confer protection against neurodegeneration, in particular in Alzheimer's disease. Finally, we will give evidence of how the involvement of BDNF in the pathogenesis of brain glioblastoma has emerged, thus opening new avenues for the treatment of this deadly cancer.
Overview
CoChat Summary
TL;DR
This review summarizes BDNF signaling through TrkB and p75NTR and its roles in synaptic plasticity, adult neurogenesis, depression, neurodegeneration, and glioblastoma. It argues that BDNF is a key mediator of antidepressant and exercise effects and a potential therapeutic target, though clinical translation remains uncertain.
Key findings
- BDNF is synthesized as preproBDNF (32–35 kDa), cleaved to proBDNF (28–32 kDa), then mature mBDNF (13 kDa); proBDNF and mBDNF can exert opposing effects via p75NTR and TrkB, respectively.
- The human BDNF gene has 11 exons and nine alternative promoters; the Val66Met polymorphism (rs6265) impairs activity-dependent BDNF secretion and has been linked to mood disorders, cognitive/neurodegenerative phenotypes, but replication is inconsistent.
- In major depressive disorder, BDNF mRNA and protein are decreased in hippocampus, prefrontal cortex, and amygdala; antidepressants increase BDNF/TrkB signaling in rodent cortex and hippocampus. Three months of aerobic exercise training increased hippocampal volume by 12% in healthy individuals and 16% in patients with schizophrenia.
- In Alzheimer’s disease, BDNF is reduced and can correlate with disease severity; mouse studies indicate exercise-induced protection requires both adult hippocampal neurogenesis and BDNF. In glioblastoma, BDNF/TrkB can promote tumor growth, but enriched environment/BDNF can also be oncolytic via IL-15/IFN-γ and TrkB.T1.
Methods
- Narrative review; no primary experiments. It synthesizes published literature on BDNF gene structure, transcripts, miRNAs, signaling, Val66Met, depression, neurodegeneration, and brain cancer.
- Evidence discussed includes rodent models, in vitro cell studies, human postmortem brain tissue, serum/platelet BDNF measures, genetic association studies, and meta-analyses.
- No systematic search strategy, inclusion criteria, or quantitative synthesis is reported.
Limitations
- The paper states that human neuroplasticity remains largely indirect because of methodological limitations and ethical constraints, and that there is no evidence that serum BDNF is related to brain BDNF and neuroplasticity.
- The paper states that Val66Met genetic findings are inconsistent, with failed replications possibly due to environmental factors, ethnicity, age, and sex.
- Evident from the text: as a narrative review, it lacks systematic search and quality appraisal; many mechanistic claims rely on rodent or in vitro models, and causal direction in human disease remains uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
59 Valid · 7 Not valid · 51 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“BDNF protein is also detectable outside of the nervous system in several non-neuronal tissues, such as in endothelial cells [17,18], cardiomyocytes [19], vascular smooth muscle cells [17], leukocytes [20], platelets [21,22], and megakaryocytes [19].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 1. Introduction
What the sources say
- Partly supportedcites [17] Nakahashi, 2000, Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor, FEBS Lett. sourceExperimental — accuracy not yet measured
Our copy squarely supports the endothelial-cell part: Results 3.1 reports BDNF protein by ELISA in HUVEC culture medium (135 +/- 67.2 pg/ml) and cell lysates (52.6 +/- 7.0 pg/ml), and in human coronary artery and bovine pulmonary artery endothelial cultures, with mRNA confirmed in 3.2. It does not support BDNF protein in vascular smooth muscle cells: in HCASMCs our copy detects only BDNF mRNA (RT-PCR 594 bp band and 4.0/1.6 kb Northern bands, Sec. 3.2/Fig. 3), no protein assay was done on smooth muscle cells, and the Introduction/Discussion credit the earlier reports of BDNF in vascular smooth muscle cells to another work ([14]), while the megakaryocytic cell line data (Meg-01, K562) actually show almost no BDNF protein (Discussion). (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [18] Wang, 2006, Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells, Eur. J. Neurosci. source
- Not checked — no full text of the sourcecites [19] 2017, BDNF-A key player in cardiovascular system, J. Mol. Cell. Cardiol. source
- Partly supportedcites [20] Anders, 2020, BDNF mRNA Expression in Leukocytes and Frontal Cortex Function in Drug Use Disorder, Front. Psychiatry sourceExperimental — accuracy not yet measured
Citation [20] is attached specifically to leukocytes. The Methods and Discussion (pages not provided) report BDNF mRNA expression in peripheral-blood leukocytes, but the paper measures RNA rather than demonstrating that BDNF protein is detectable in those cells. The other cell types have separate citations and are not assessed here. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several lines of evidence also suggest that the BDNF/TrkB signaling is involved in adult neurogenesis in the hippocampus with differing effects in the dentate gyrus (DG) and subventricular zone (SVZ) [5].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 1. Introduction
What the sources say
- Partly supportedcites [5] Vilar, 2016, Regulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles, Front. Neurosci. sourceExperimental — accuracy not yet measured
The section on the SGZ says BDNF/TrkB is important for adult hippocampal neurogenesis, while the section on the SVZ describes different, mixed effects on SVZ proliferation and olfactory-bulb neurogenesis. The claim is imprecise in placing both the dentate gyrus and SVZ within the hippocampus; the paper treats them as distinct neurogenic niches. No page numbers were supplied for these passages. (LLM, conf=0.87)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The functionality of BDNF Val66Met variant was only confirmed in 2003 [112], where BDNF Val66Met polymorphism was shown to disrupt the episodic memory in humans.”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.4. The Human BDNF Variant Val66Met
What the sources say
- Supportedcites [112] Egan, 2003, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function, Cell source
The Results report that met/met subjects scored lower on a test of verbal episodic memory, with a significant effect of BDNF genotype in both controls and the full cohort. The Discussion concludes that the polymorphism has significant effects on human verbal episodic memory. This supports the claim that Val66Met impairs episodic memory in humans. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The pro-domain of BDNF is the locus of a functional human BDNF polymorphism (SNPs) Val66Met, also known as rs6265 or G196Apolymorphism [109].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.4. The Human BDNF Variant Val66Met
What the sources say
- Partly supportedcites [109] Petryshen, 2010, Population genetic study of the brain-derived neurotrophic factor (BDNF) gene, Mol. Psychiatry sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) places Val66Met at position 66 of the proBDNF protein and describes its role in neuronal and cognitive function. Results > Global diversity of BDNF SNPs (page unavailable) identifies Val66Met as rs6265. Our copy does not identify it as G196A or explicitly locate it in the pro-domain, so those details remain unsupported by this source. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“mBDNF-TrkB-signaling pathways regulate multiple events, such as apoptosis and survival of neurons [90,91,92], dendritic growth [93,94,95,96], spine maturation and stabilization, development of synapses [96,97,98], learning- and memory-processes-dependent synaptic plasticity [99,100].”
§ Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer > 2. The Human BDNF Gene: Transcripts and Variants > 2.3. Biology of BDNF
What the sources say
- Partly supportedcites [90] Patel, 2010, BDNF is required for the survival of differentiated geniculate ganglion neurons, Dev. Biol. sourceExperimental — accuracy not yet measured
This source is cited for the apoptosis and neuronal-survival portion of the sentence, not the later claims about dendrites, synapses, or plasticity. The Discussion reports that BDNF prevents death of differentiated geniculate ganglion neurons by suppressing Bax-dependent cell death, and links BDNF loss to increased activated caspase-3. Our copy does not establish that this effect specifically involves mature BDNF–TrkB signaling. (LLM, conf=0.82)
- Partly supportedcites [91] Chen, 2013, Neuroprotective effect of human placenta-derived cell treatment of stroke in rats, Cell Transplant. sourceExperimental — accuracy not yet measured
Our copy of Chen et al. (2013) supports only the apoptosis/survival facet of the claim, and only in a rat focal-stroke context: the Discussion states 'BDNF also plays an important role in promoting neuroprotection after stroke' and the Abstract/Conclusion attribute PDA001's neuroprotective effects to 'the increase of VEGF, HGF, and BDNF expression, and a decrease of apoptosis' (with reduced TUNEL and cleaved caspase 3, Discussion). The TrkB receptor/signalling pathway is never mentioned, and no passage addresses the other events the claim attributes to mBDNF-TrkB signalling — dendritic growth, spine maturation and stabilization, synapse development, or learning- and memory-dependent synaptic plasticity (searched: 'TrkB', 'BDNF signaling', 'dendritic growth spine synaptogenesis synaptic plasticity learning memory'). The paper is also an intervention study measuring BDNF protein by ELISA/immunostaining, not a source for the general regulatory roles listed in the citing sentence. (LLM, conf=0.65)
- Not checked — no full text of the sourcecites [92] Wu, 2019, Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice, Neurotox. Res. source
- Supportedcites [93] Gorski, 2003, Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites, J. Neurosci. source
This source is cited in the group attached to dendritic growth, not the separately cited claims about neuronal survival or learning and memory. Its Introduction states that BDNF and TrkB signaling can influence cortical dendrite growth, and the section ‘BDNF is required for maintenance of neuronal morphology’ reports a requirement for BDNF in maintaining cortical dendritic structure. Page numbers are unavailable in our copy. (LLM, conf=0.91)
- Supportedcites [94] Kwon, 2011, BDNF-promoted increases in proximal dendrites occur via CREB-dependent transcriptional regulation of cypin, J. Neurosci. source
This source supports the dendritic-growth portion of the sentence, rather than the separately cited claims about survival or learning and memory. The Introduction describes BDNF as a regulator of dendrite outgrowth and branching, and the Discussion reports BDNF-dependent increases in proximal dendrite number in hippocampal neurons. (LLM, conf=0.91)
- Partly supportedcites [95] Orefice, 2013, Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines, J. Neurosci. sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that BDNF synthesized in dendrites regulates spine maturation and pruning, and the section on corresponding synaptic changes reports effects on excitatory synapse number and size. Those findings support the spine-maturation and synapse-development portions associated with this citation. Our copy does not establish dendritic growth or spine stabilization, or identify TrkB signaling as the mechanism for these effects; the citations attached to apoptosis and learning-dependent plasticity are different references. (LLM, conf=0.86)
- Supportedcites [96] Zagrebelsky, M., Tacke, C., and Korte, M. (2020). BDNF signaling during the lifetime of dendritic spines. Cell Tissue Res. source
This source is cited for dendritic growth and for spine maturation, stabilization, and synapse development, rather than for the separately cited claims about neuronal survival and learning. The Introduction describes BDNF signaling in spine formation and maintenance, and “Dendritic spine maturation and stabilization” explicitly says maturation depends on TrkB signaling. The review also reports TrkB-related regulation of dendritic morphology; because spines form the postsynaptic part of most excitatory synapses, its account of spine formation supports the synapse-development point. (LLM, conf=0.86)
- Could not verifycites [99] Opazo, 2003, Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms, J. Neurosci. sourceExperimental — accuracy not yet measured
The Introduction discusses Ras, PI3-kinase and MAPK signaling in long-term potentiation, but does not connect those findings to mBDNF–TrkB signaling. Searches of our copy for BDNF and TrkB found no passage addressing whether that pathway regulates learning- or memory-related synaptic plasticity. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [100] Leal, 2017, BDNF and Hippocampal Synaptic Plasticity, Vitam. Horm. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
75 more claims · 23 with their cited sources checked
Create a free account to see all 135 claims and to verify the 23 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 14
Citations
Cites
Items 201–265 of 265
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
(2020) · doi:10.3390/ijms21020505 · Cited by 63
Self-citationRapid activation of ERK by 6‐hydroxydopamine promotes survival of dopaminergic cells
Lin, E., Cavanaugh, J. E., Leak, R. K., Perez, R. G., & Zigmond, M. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21478 · Cited by 62
Sakata, K., & Duke, S. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.013 · Cited by 60
Environmental stimuli shape microglial plasticity in glioma
Garofalo, S., Porzia, A., Mainiero, F., Di Angelantonio, S., Cortese, B., Basilico, B., Pagani, F., Cignitti, G., Chece, G., Maggio, R., et al. (2017) · eLife · doi:10.7554/elife.33415 · Cited by 58
The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer’s Disease
Hoxha, E., Lippiello, P., Zurlo, F., Balbo, I., Santamaria, R., Tempia, F., & Miniaci, M. C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00396 · Cited by 58
miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation
Gregorio, R. D., Pulcrano, S., Sanctis, C. D., Volpicelli, F., Guatteo, E., von Oerthel, L., Latagliata, E. C., Esposito, R., Piscitelli, R. M., Perrone‐Capano, C., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.006 · Cited by 57
Self-citationZheng, F., & Wang, H. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.006 · Cited by 55
Lieb, K., Dreimüller, N., Wagner, S., Schlicht, K., Falter, T., Neyazi, A., Müller-Engling, L., Bleich, S., Tadić, A., & Frieling, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00511 · Cited by 54 · cited 1×
“Preliminary evidence has demonstrated that patients with major depressive disorder (MDD) present a hypomethylation of the CpG-87 site of the promoter IV region of BDNF gene and are less likely to benefit from antidepressants [47,48].”
BackgroundPhylogenesis of brain-derived neurotrophic factor (BDNF) in vertebrates
Tettamanti, G., Cattaneo, A. G., Gornati, R., de Eguileor, M., Bernardini, G., & Binelli, G. (2009) · Gene · doi:10.1016/j.gene.2009.07.023 · Cited by 54
Hill, J. L., Hardy, N. F., Jimenez, D. V., Maynard, K. R., Kardian, A. S., Pollock, C. J., Schloesser, R. J., & Martinowich, K. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.153 · Cited by 52
Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer’s Disease Mice
Bartolotti, N., Segura, L., & Lazarov, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150650 · Cited by 52
Kheirollahi, M., Kazemi, E., & Ashouri, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0229-z · Cited by 50
Yang, C., Zhang, X., Liu, Y., Du, J., Liang, R., Yu, M., Zhang, F. Q., Mu, X., Li, F., Zhou, L., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00101-2 · Cited by 49
BDNF is required for the survival of differentiated geniculate ganglion neurons
Patel, A. V., & Krimm, R. F. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.01.024 · Cited by 48
The BDNF Val66Met Polymorphism Affects the Vulnerability of the Brain Structural Network
Park, C.-H., Kim, J., Namgung, E., Lee, D.-W., Kim, G. H., Kim, M., Kim, N., Kim, T. D., Kim, S., Lyoo, I. K., et al. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00400 · Cited by 47
Chen, N.-C., Chuang, Y., Huang, C., Lui, C., Lee, C., Hsu, S., Lin, P., Lu, Y., Chang, Y., Hsu, C.-W., et al. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.02.029 · Cited by 46
Yan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46
Effect of Clotting Duration and Temperature on BDNF Measurement in Human Serum
Amadio, P., Sandrini, L., Ieraci, A., Tremoli, E., & Barbieri, S. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091987 · Cited by 45
Wang, Q., Liu, J., Guo, Y., Dong, G., Zou, W., & Chen, Z. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198443 · Cited by 45
Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment
Altmann, V., Schumacher-Schuh, A. F., Rieck, M., Callegari-Jacques, S. M., Rieder, C. R. M., & Hutz, M. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.030 · Cited by 43
Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function
Mariga, A., Zavadil, J., Ginsberg, S. D., & Chao, M. V. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22216 · Cited by 43
BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia
Han, M., & Deng, C. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.015 · Cited by 41
Targeting TrkB neurotrophin receptor to treat depression
Rantamäki, T., & Castrén, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.705 · Cited by 40
A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer’s Disease
Keifer, J., Zheng, Z., & Ambigapathy, G. (2015) · MicroRNA · doi:10.2174/2211536604666150813152620 · Cited by 40
Colucci-D’Amato, L., & Cimaglia, G. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2020.05.002 · Cited by 40
Self-citationVal66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression
Caldieraro, M. A., McKee, M., Leistner-Segal, S., Vares, E. A., Kubaski, F., Spanemberg, L., Brusius-Facchin, A. C., Fleck, M. P., & Mischoulon, D. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1347713 · Cited by 39
Brown, A., Machan, J. T., Hayes, L., & Zervas, M. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22710 · Cited by 39
XIONG, J., ZHOU, L., LIM, Y., YANG, M., ZHU, Y.-H., LI, Z.-W., FU, D.-L., & ZHOU, X.-F. (2015) · Oncology Letters · doi:10.3892/ol.2015.3181 · Cited by 38
TrkB but not trkC receptors are necessary for postnatal maintenance of hippocampal spines
von Bohlen und Halbach, O., Minichiello, L., & Unsicker, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.028 · Cited by 37
Volpicelli, F., Speranza, L., Pulcrano, S., Gregorio, R. D., Crispino, M., Sanctis, C. D., Leopoldo, M., Lacivita, E., di Porzio, U., Bellenchi, G. C., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01690-x · Cited by 37
Self-citationHashimoto, T., Fukui, K., Takeuchi, H., Yokota, S., Kikuchi, Y., Tomita, H., Taki, Y., & Kawashima, R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw020 · Cited by 37
Colucci-D'Amato, G. L., D'Alessio, A., Califano, D., Calı̀, G., Rizzo, C., Nitsch, L., Santelli, G., & de Franciscis, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.25.19306 · Cited by 37
You, Y., Qin, Z.-Q., Zhang, H.-L., Zhao-hong, Y., & Yu, X. (2019) · Bioscience Reports · doi:10.1042/bsr20181904 · Cited by 35
Xia, H., Du, X., Yin, G., Zhang, Y., Li, X., Cai, J., Huang, X., Ning, Y., Soares, J. C., Wu, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36419-8 · Cited by 35
Cazorla, M., Arrang, J., & Prémont, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01094.x · Cited by 35
Park, S. W., Nhu, L. H., Cho, H. Y., Seo, M. K., Lee, C. H., Ly, N. N., Choi, C. M., Lee, B. J., Kim, G.-M., Seol, W., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.010 · Cited by 33
Gentile, M. T., Nawa, Y., Lunardi, G., Florio, T., Matsui, H., & Colucci-D’Amato, L. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12004 · Cited by 31
Self-citationImplications of p75NTR for dentate gyrus morphology and hippocampus-related behavior revisited
Dokter, M., Busch, R., Poser, R., Vogt, M. A., von Bohlen und Halbach, V., Gass, P., Unsicker, K., & von Bohlen und Halbach, O. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0737-5 · Cited by 31
Zhao, X., Shu, F., Wang, X., Wang, F., Wu, L., Li, L., & Lv, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.035 · Cited by 30
Acute Exercise Intensity and Memory Function: Evaluation of the Transient Hypofrontality Hypothesis
Loprinzi, P. D., Day, S., & Deming, R. (2019) · Medicina · doi:10.3390/medicina55080445 · Cited by 26
Colucci-D’Amato, L., Farina, A., Vissers, J. P. C., & Chambery, A. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9136-3 · Cited by 26
Self-citationTraining old rats selectively modulates synaptosomal protein synthesis
Eyman, M., Cefaliello, C., Mandile, P., Piscopo, S., Crispino, M., & Giuditta, A. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23133 · Cited by 25
Is fragile X mental retardation protein involved in activity-induced plasticity of dendritic spines?
Segal, M., Kreher, U., Greenberger, V., & Braun, K. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02410-7 · Cited by 25
Piotrowicz, Z., Chalimoniuk, M., Płoszczyca, K., Czuba, M., & Langfort, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155569 · Cited by 24
BDNF Val66Met polymorphism and cognitive impairment in Parkinson’s disease—a meta-analysis
Yin, Y., Su, X., Pan, L., & Li, C. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03907-2 · Cited by 23
MicroRNA‐107 regulates anesthesia‐induced neural injury in embryonic stem cell derived neurons
Jiang, J., Zheng, X. C., Huang, F., Gao, F., You, M. Z., & Zheng, T. (2018) · IUBMB Life · doi:10.1002/iub.1911 · Cited by 22
Neurogenesis in adult CNS: From denial to opportunities and challenges for therapy
Colucci‐D'Amato, L., & di Porzio, U. (2008) · BioEssays · doi:10.1002/bies.20703 · Cited by 22
Self-citationNizzari, M., Barbieri, F., Gentile, M. T., Passarella, D., Caorsi, C., Diaspro, A., Taglialatela, M., Pagano, A., Colucci-D'Amato, L., Florio, T., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101590 · Cited by 21
Self-citationXin, C., Xia, J., Liu, Y., & Zhang, Y. (2020) · PubMed Central · doi:10.2147/ndt.s241136 · Cited by 21
Dalby, R. B., Elfving, B., Poulsen, P. H. P., Foldager, L., Frandsen, J., Videbech, P., & Rosenberg, R. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12085 · Cited by 21
Lieto, A. D., Leo, D., Volpicelli, F., di Porzio, U., & Colucci-D’Amato, L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.076 · Cited by 19
Self-citationXia, H., Zhang, G., Du, X., Zhang, Y., Yin, G., Dai, J., He, M., Soares, J. C., Li, X., & Zhang, X. (2017) · Neuropsychology · doi:10.1037/neu0000383 · Cited by 18
BDNF and COMT, but not APOE, alleles are associated with psychiatric symptoms in refractory epilepsy
Doherty, C. M., Hogue, O., Floden, D. P., Altemus, J. B., Najm, I., Eng, C., & Busch, R. M. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.02.032 · Cited by 18
Novel BDNF-regulatory microRNAs in neurodegenerative disorders pathogenesis: An in silico study
Khani-Habibabadi, F., Askari, S., Zahiri, J., Javan, M., & Behmanesh, M. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107153 · Cited by 18 · cited 1×
“A number of recent studies, obtained from high throughput sequencing screening of different brain regions or from neurological disorders, have identified seven miRNAs (miR-15a, miR-206, miR-155-5p, miR-16, miR-103-3p, miR-330-3p, Let-7a-3p) correlated with BDNF [55].”
BackgroundHuang, E., Hettige, N. C., Zai, G. C., Tomasi, J., Huang, J., Zai, C. C. H., Pivac, N., Perković, M. N., Tiwari, A. K., & Kennedy, J. L. (2018) · The Pharmacogenomics Journal · doi:10.1038/s41397-018-0041-5 · Cited by 17
Severino, V., Farina, A., Colucci-D’Amato, L., Reccia, M. G., Volpicelli, F., Parente, A., & Chambery, A. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.12.005 · Cited by 17
Self-citationBDNF mRNA Expression in Leukocytes and Frontal Cortex Function in Drug Use Disorder
Anders, Q. S., Ferreira, L. V. B., Rodrigues, L. C. D. M., & Nakamura-Palacios, E. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00469 · Cited by 15 · cited 2×
“BDNF protein is also detectable outside of the nervous system in several non-neuronal tissues, such as in endothelial cells [17,18], cardiomyocytes [19], vascular smooth muscle cells [17], leukocytes [20], platelets [21,22], and megakaryocytes [19].”
BackgroundLohia, R., Salari, R., & Brannigan, G. H. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007390 · Cited by 15
Nawa, Y., Kaneko, H., Oda, M., Tsubonoya, M., Hiroi, T., Gentile, M. T., Colucci-D’Amato, L., Takahashi, R., & Matsui, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14060 · Cited by 14
Self-citationSidhu, M. K., Thompson, P. J., Wandschneider, B., Foulkes, A. L., de Tisi, J., Stretton, J., Perona, M., Thom, M., Bonelli, S. B., Burdett, J. L., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13003 · Cited by 13
Excessive Treadmill Training Enhances Brain-Specific MicroRNA-34a in the Mouse Hippocampus
Lin, X., Zheng, Y., Yin, X., Xu, S. J., Dong, T., Zhang, C. Y., Wang, S., & Zheng, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00007 · Cited by 12
Morin‐Moncet, O., Latulipe-Loiselle, A., Therrien-Blanchet, J.-M., & Théoret, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197505 · Cited by 12
Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice
Wu, Y., Wang, R., Wang, Y., Gao, J., Feng, L., & Yang, Z. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00075-1 · Cited by 9 · cited 1×
“BDNF mice lacking BDNF die during the second postnatal week [176] and BDNF deficit causes inhibition of dendritic arborization [92, 177] and reduction of expression of genes functionally related to vesicular trafficking and synaptic communication [178].”
BackgroundTsai, S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109560 · Cited by 2
Lohia, R., Salari, R., & Brannigan, G. H. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8135777 · Cited by 1
Cited by
Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
Wu, A., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02964-x · Cited by 306
The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications
Hadidi, M., Liñán-Atero, R., Tarahi, M., Christodoulou, M. C., & Aghababaei, F. (2024) · Antioxidants · doi:10.3390/antiox13081001 · Cited by 263
Azman, K. F., & Zakaria, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126827 · Cited by 221
Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy
Zhou, X., Deng, X., Liu, M., He, M., Long, W., Xu, Z., Zhang, K., Liu, T., So, K., Fu, Q., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.033 · Cited by 169
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Metadata
- Authors
- Colucci-D’Amato, L., Speranza, L., & Volpicelli, F.
- Affiliations
- University of Campania "Luigi Vanvitelli" (IT)
- Albert Einstein College of Medicine (US)
- University of Naples Federico II (IT)
- Corresponding author
- Colucci-D’Amato, Luca
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-21
- Volume
- 21
- Issue
- 20
- Pages
- 7777
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589016
- OpenAlex
- W3094053673
- Semantic Scholar
- b708532c0091c2277fb96a67cf47858ee098c33a
- Cited by
- 991
- References
- 271
- Citations by year
- 2026: 149 · 2025: 251 · 2024: 230 · 2023: 187 · 2022: 122 · 2021: 49 · 2020: 3
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- brain-derived neurotrophic factor, TrkB receptor, p75 neurotrophin receptor, neuroplasticity, synaptic plasticity, dendritic spines, adult neurogenesis, hippocampus, depression, antidepressant treatment, neurodegeneration, Alzheimer's disease, glioblastoma, neuroprotection, learning and memory
- MeSH terms
- Animals, Antidepressive Agents, Brain Neoplasms, Depression, Humans, Neuronal Plasticity, Oncogenes, Genes, Tumor Suppressor, Neuroprotective Agents, Brain-Derived Neurotrophic Factor, Neurodegenerative Diseases, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.